The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.
USGI Medical says it raised $19.5 million in new debt and equity financing to fuel international commercial plans and U.S. regulatory efforts for its endoscopic weight-loss device.
California's USGI Medical said it raised $19.5 million in new equity and debt financing designed, in part, to back the final stages of the U.S. approval process for an incision-less endoscopic weight-loss procedure known as POSE.
Here's a look at some of the top Wall Street stories for medical device companies this week: Asante Solutions sets IPO terms; Stryker CEO Lobo: M&A is our top priority for cash; Abiomed surges on Q3 numbers, FDA nod; Credit agencies lower Medtronic's rating post-Covidien merger
Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.
This post is a frank call to action. Massachusetts is one of the few remaining states in the country that does not provide coverage for telemedicine services through its Medicaid program, and credentialing and reimbursement issues have helped the expansion of telehealth programs at Boston Children's Hospital and beyond.
A former Medtronic worker sues the company and police in Brooklyn Park, Minn., alleging false arrest and imprisonment after he was taken into custody as a suspect in a pair of hoax bomb threats made against the medical device company 2 years ago.